Martin Vogelbaum, Director at Cara Therapeutics, Inc. (CARA), bought 495,454 shares at $4.93 ($2.4M) on 2016-03-17, disclosed to the SEC on 2016-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.93 | 247,727 | $1.2M | 50.0% |
| 2 | $4.93 | 247,727 | $1.2M | 50.0% |
| Total | $4.93 avg | 495,454 | $2.4M | 100% |
| Filing → |
| CARA | SELL | 2020-11-19 | $97K | — | Filing → |
| CARA | BUY | 2014-02-05 | $2.5M | — | Filing → |